As more patients come forward with questions about the potential link between dupilumab (Dupixent®) and certain types of cancer, it’s…
Read More →
On Friday, October 3, 2025, the United States Supreme Court announced that it will provide vital guidance regarding the extent…
Read More →
US public companies increasingly embrace digital assets as part of their corporate treasury strategies. Known as digital asset treasury (DAT)…
Read More →
In the last decade, various large cities including New York City, Philadelphia, Chicago, Seattle, San Francisco, Emeryville, and Los Angeles…
Read More →
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health…
Read More →
Our Investment Funds and Securities Litigation teams explain how the Securities and Exchange Commission (SEC) has clarified the treatment of…
Read More →
On September 15, 2025, the Office of the Director of National Intelligence (“DNI”) published the first exclusion and removal order (“Order”) under…
Read More →
When it comes to insurance claim practices handled in bad faith, the Golden State is an unfortunate leader. In August…
Read More →
Across Ontario and beyond, more people are facing disability claim denials from their insurance providers. For individuals already coping with…
Read More →
On October 3, 2025, the U.S. Supreme Court granted plaintiff’s Petition for a Writ of Certiorari in Montgomery v. Caribe…
Read More →